Stockscreener 앱 받기
12.40
1.04%
-0.13
시간 외 거래:
12.40
전일 마감가:
$12.53
열려 있는:
$12.56
하루 거래량:
1.82M
Relative Volume:
0.94
시가총액:
$1.63B
수익:
$260.11M
순이익/손실:
$60.64M
주가수익비율:
28.84
EPS:
0.43
순현금흐름:
$92.29M
1주 성능:
+3.42%
1개월 성능:
+5.98%
6개월 성능:
+43.02%
1년 성능:
+79.45%
1일 변동 폭
$12.36
$12.82
1주일 범위
$11.57
$12.82
52주 변동 폭
$6.42
$12.82
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
명칭
Aurinia Pharmaceuticals Inc
전화
250-744-2487
주소
#140, 14315 - 118 AVENUE, EDMONTON, BC
AUPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
12.40 | 1.65B | 260.11M | 60.64M | 92.29M | 0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 재개 | H.C. Wainwright | Buy |
| 2022-11-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-05-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-12-10 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-01-25 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-03 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 개시 | BTIG Research | Buy |
| 2020-05-05 | 개시 | Cowen | Outperform |
| 2020-01-10 | 개시 | Jefferies | Buy |
| 2019-12-16 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-16 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-02-08 | 개시 | RBC Capital Mkts | Outperform |
| 2017-10-30 | 재확인 | H.C. Wainwright | Buy |
| 2017-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2017-04-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-03-22 | 재확인 | FBR & Co. | Outperform |
| 2016-12-30 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-17 | 재확인 | H.C. Wainwright | Buy |
| 2016-06-30 | 개시 | H.C. Wainwright | Buy |
| 2015-05-08 | 개시 | MLV & Co | Buy |
모두보기
Aurinia Pharmaceuticals Inc 주식(AUPH)의 최신 뉴스
Regression analysis insights on Aurinia Pharmaceuticals Inc. performance2025 Technical Patterns & Growth Focused Stock Pick Reports - Newser
How does Aurinia Pharmaceuticals Inc. compare to its peers2025 Geopolitical Influence & Accurate Intraday Trading Signals - خودرو بانک
Real time alert setup for Aurinia Pharmaceuticals Inc. performanceTrend Reversal & Safe Capital Allocation Plans - Newser
Why is Aurinia Pharmaceuticals Inc. stock going downQuarterly Performance Summary & Expert Approved Trade Ideas - خودرو بانک
Is Aurinia Pharmaceuticals Inc. attractive at current valuationVolume Spike & Fast Moving Stock Trade Plans - خودرو بانک
Can machine learning forecast Aurinia Pharmaceuticals Inc. recoveryEarnings Growth Report & Weekly Breakout Stock Alerts - Newser
Analyzing Aurinia Pharmaceuticals Inc. with risk reward ratio charts2025 Winners & Losers & Free Community Supported Trade Ideas - Newser
Quantitative breakdown of Aurinia Pharmaceuticals Inc. recent move2025 Performance Recap & Advanced Technical Analysis Signals - Newser
Evaluating Aurinia Pharmaceuticals Inc. with trendline analysisPortfolio Growth Summary & Smart Money Movement Tracker - Newser
Using economic indicators to assess Aurinia Pharmaceuticals Inc. potential2025 Trade Ideas & High Win Rate Trade Tips - Newser
Can a trend reversal in Aurinia Pharmaceuticals Inc. lead to recoveryWeekly Profit Analysis & Stepwise Entry and Exit Trade Signals - Newser
Dow Update: What are Aurinia Pharmaceuticals Inc.’s technical support levelsMarket Growth Summary & Real-Time Stock Movement Alerts - خودرو بانک
Full technical analysis of Aurinia Pharmaceuticals Inc. stockWeekly Profit Report & Verified Stock Trade Ideas - Newser
Aurinia Pharmaceuticals stock hits 52-week high at 12.55 USD - Investing.com
Will Aurinia Pharmaceuticals Inc. face regulatory challengesDay Trade & Verified Technical Signals - خودرو بانک
What Fibonacci levels say about Aurinia Pharmaceuticals Inc. rebound2025 Market Overview & Real-Time Volume Analysis Alerts - Newser
Advanced analytics toolkit walkthrough for Aurinia Pharmaceuticals Inc.Bond Market & Smart Investment Allocation Insights - Newser
How to integrate Aurinia Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Drop Watch & Daily Profit Maximizing Trade Tips - Newser
Applying Elliott Wave Theory to Aurinia Pharmaceuticals Inc.July 2025 News Drivers & AI Based Buy/Sell Signal Reports - Newser
Can Aurinia Pharmaceuticals Inc. hit a new high this monthTrade Volume Summary & Daily Chart Pattern Signals - Newser
Will Aurinia Pharmaceuticals Inc. bounce back from current support2025 Technical Patterns & Safe Entry Momentum Stock Tips - Newser
Is Aurinia Pharmaceuticals Inc. showing insider buyingTrade Volume Report & Stock Timing and Entry Methods - خودرو بانک
How sentiment analysis helps forecast Aurinia Pharmaceuticals Inc.July 2025 Catalysts & Smart Allocation Stock Reports - Newser
Can Aurinia Pharmaceuticals Inc. grow without external fundingWeekly Stock Report & Weekly High Conviction Ideas - خودرو بانک
Visual analytics tools that track Aurinia Pharmaceuticals Inc. performanceJuly 2025 Setups & Daily Volume Surge Trade Alerts - Newser
Should I set a stop loss on Aurinia Pharmaceuticals Inc.Earnings Trend Report & Fast Exit and Entry Strategy Plans - خودرو بانک
Nephrotic Syndrome Pipeline Analysis, 2025 by DelveInsight | GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharmaceuticals, Bristol-Myers Squibb, ChemoCentryx, SynAct Pharm - Barchart.com
Will Aurinia Pharmaceuticals Inc. benefit from government policyWeekly Market Report & Free Technical Pattern Based Buy Signals - خودرو بانک
Is Aurinia Pharmaceuticals Inc. gaining market share2025 Top Decliners & Low Risk High Win Rate Stock Picks - خودرو بانک
What is Aurinia Pharmaceuticals Inc.’s market position2025 Market WrapUp & Verified Momentum Watchlists - خودرو بانک
Aurinia Pharmaceuticals Inc. stock trend outlook and recovery pathBond Market & Weekly Momentum Stock Picks - Newser
Published on: 2025-09-02 04:45:19 - Newser
Multi factor analysis applied to Aurinia Pharmaceuticals Inc.July 2025 Reactions & Free Growth Oriented Trading Recommendations - Newser
What are Aurinia Pharmaceuticals Inc.’s technical support levelsCPI Data & Daily Entry Point Trade Alerts - خودرو بانک
Can Aurinia Pharmaceuticals Inc. sustain earnings growthMarket Sentiment Summary & Weekly Breakout Stock Alerts - خودرو بانک
What makes Aurinia Pharmaceuticals Inc. stock attractive today2025 Top Decliners & Real-Time Price Movement Reports - خودرو بانک
Does Aurinia Pharmaceuticals Inc. offer margin of safetyMarket Risk Analysis & Real-Time Price Movement Reports - خودرو بانک
Aurinia Pharmaceuticals Inc. Reversal Rally May Surprise Bears getLinesFromResByArray error: size == 0 - 강소기업뉴스
Is Aurinia Pharmaceuticals Inc. forming a bottoming baseTrade Volume Summary & Weekly High Momentum Picks - Newser
Using data filters to optimize entry into Aurinia Pharmaceuticals Inc.Market Trend Review & Reliable Entry Point Alerts - Newser
Aurinia Pharmaceuticals Inc (AUPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aurinia Pharmaceuticals Inc 주식 (AUPH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| TANG KEVIN | Director |
Aug 05 '25 |
Buy |
11.68 |
200,000 |
2,336,000 |
11,329,500 |
| TANG KEVIN | Director |
Aug 04 '25 |
Buy |
11.34 |
100,000 |
1,134,000 |
11,129,500 |
| Keenan Greg | Chief Medical Officer |
Aug 01 '25 |
Sale |
10.50 |
20,000 |
210,000 |
133,484 |
| Keenan Greg | Chief Medical Officer |
Mar 07 '25 |
Sale |
8.23 |
8,305 |
68,350 |
153,484 |
| Greenleaf Peter | Chief Executive Officer |
Mar 03 '25 |
Sale |
8.00 |
195,593 |
1,564,744 |
1,953,892 |
| Greenleaf Peter | Chief Executive Officer |
Mar 04 '25 |
Sale |
7.92 |
164,947 |
1,306,380 |
1,788,945 |
| Keenan Greg | Chief Medical Officer |
Mar 03 '25 |
Sale |
8.00 |
12,239 |
97,912 |
161,789 |
| Miller Joseph M | Chief Financial Officer |
Mar 03 '25 |
Sale |
8.00 |
61,859 |
494,872 |
633,515 |
| Miller Joseph M | Chief Financial Officer |
Mar 04 '25 |
Sale |
7.92 |
56,154 |
444,740 |
577,361 |
| Robertson Stephen P. | EVP, General Counsel |
Mar 03 '25 |
Sale |
8.00 |
64,872 |
518,976 |
566,883 |
1.40%
자본화:
|
볼륨(24시간):